NCT00005863View on ClinicalTrials.gov

Combination Chemotherapy With or Without Filgrastim and/or Tretinoin in Treating Patients With Acute Myeloid Leukemia

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

August 31, 1998

Study Completion Date

December 31, 2004

Conditions
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
Interventions
BIOLOGICAL

filgrastim

DRUG

cytarabine

DRUG

daunorubicin hydrochloride

DRUG

etoposide

DRUG

fludarabine phosphate

DRUG

tretinoin

Trial Locations (1)

B9 5SS

Birmingham Heartlands Hospital, Birmingham

Sponsors
All Listed Sponsors
lead

Medical Research Council

OTHER_GOV

NCT00005863 - Combination Chemotherapy With or Without Filgrastim and/or Tretinoin in Treating Patients With Acute Myeloid Leukemia | Biotech Hunter | Biotech Hunter